losoxantrone has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beggiolin, G; Capranico, G; Carenini, N; Dal Bo, L; Facchinetti, F; Guano, F; Menta, E; Palumbo, M; Pavesi, R; Pezzoni, G; Polizzi, D; Pratesi, G; Richter, S; Sissi, C; Spinelli, S; Supino, R; Torriani, D; Tortoreto, M; Zunino, F | 1 |
1 other study(ies) available for losoxantrone and Adenocarcinoma
| Article | Year |
|---|---|
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.
Topics: Adenocarcinoma; Animals; Anthraquinones; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Division; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Ethanolamines; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Intercalating Agents; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyrazolones; Remission Induction; Xenograft Model Antitumor Assays | 2001 |